Literature DB >> 16424026

Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.

Shyamal D Desai1, Arthur L Haas, Laurence M Wood, Yu-Chen Tsai, Sidney Pestka, Eric H Rubin, Ahamed Saleem, Alam Nur-E-Kamal, Leroy F Liu.   

Abstract

IFN-stimulatory gene factor 15 (ISG15) is a ubiquitin-like protein, which is conjugated to many cellular proteins. However, its role in protein degradation is unclear. Here, we show that ISG15 is highly elevated and extensively conjugated to cellular proteins in many tumors and tumor cell lines. The increased levels of ISG15 in tumor cells were found to be associated with decreased levels of polyubiquitinated proteins. Specific knockdown of ISG15 expression using ISG15-specific small interfering RNA (siRNA) was shown to increase the levels of polyubiquitinated proteins, suggesting an antagonistic role of ISG15 in regulating ubiquitin-mediated protein turnover. Moreover, siRNA-mediated down-regulation of the major E2 for ISG15 (UbcH8), which blocked the formation of ISG15 protein conjugates, also increased the levels of polyubiquitinated proteins. Together, our results suggest that the ISG15 pathway, which is deregulated during tumorigenesis, negatively regulates the ubiquitin/proteasome pathway by interfering with protein polyubiquitination/degradation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424026     DOI: 10.1158/0008-5472.CAN-05-1123

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  69 in total

1.  Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-α via type I interferon-dependent and -independent pathways.

Authors:  Kongthawat Chairatvit; Ariyaphong Wongnoppavich; Sirinthip Choonate
Journal:  Mol Cell Biochem       Date:  2012-06-23       Impact factor: 3.396

Review 2.  Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.

Authors:  Shyamal Desai; Meredith Juncker; Catherine Kim
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-09

3.  ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP.

Authors:  Fumihiko Okumura; Weiguo Zou; Dong-Er Zhang
Journal:  Genes Dev       Date:  2007-02-01       Impact factor: 11.361

Review 4.  Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.

Authors:  Ian F Pitha-Rowe; Paula M Pitha
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-03       Impact factor: 7.638

5.  Increased ISGylation in Cases of TBI-Exposed ALS Veterans.

Authors:  Joshua Schwartzenburg; Meredith Juncker; Ryan Reed; Shyamal Desai
Journal:  J Neuropathol Exp Neurol       Date:  2019-03-01       Impact factor: 3.685

6.  Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation.

Authors:  Jun-Bao Fan; Sayuri Miyauchi-Ishida; Kei-ichiro Arimoto; Dan Liu; Ming Yan; Chang-Wei Liu; Balázs Győrffy; Dong-Er Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-29       Impact factor: 11.205

7.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

8.  Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation.

Authors:  Fumihiko Okumura; Akiko J Okumura; Keiji Uematsu; Shigetsugu Hatakeyama; Dong-Er Zhang; Takumi Kamura
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

9.  ISG15 as a novel tumor biomarker for drug sensitivity.

Authors:  Shyamal D Desai; Laurence M Wood; Yu-Chen Tsai; Tao-Shih Hsieh; Jeffrey R Marks; Georgia L Scott; Beppino C Giovanella; Leroy F Liu
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

10.  Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway.

Authors:  C S Busso; T Iwakuma; T Izumi
Journal:  Oncogene       Date:  2009-02-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.